Terri B. Sebree
2021
In 2021, Terri B. Sebree earned a total compensation of $1.6M as President at Zynerba Pharmaceuticals, a 44% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $288,933 |
|---|---|
| Option Awards | $303,409 |
| Salary | $464,409 |
| Stock Awards | $537,000 |
| Other | $10,685 |
| Total | $1,604,436 |
Sebree received $537K in stock awards, accounting for 33% of the total pay in 2021.
Sebree also received $288.9K in non-equity incentive plan, $303.4K in option awards, $464.4K in salary and $10.7K in other compensation.
Rankings
In 2021, Terri B. Sebree's compensation ranked 6,962nd out of 12,415 executives tracked by ExecPay. In other words, Sebree earned more than 43.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,962 out of 12,415 | 44th |
Division Manufacturing | 3,048 out of 5,508 | 45th |
Major group Chemicals And Allied Products | 1,351 out of 2,378 | 43rd |
Industry group Drugs | 1,206 out of 2,099 | 43rd |
Industry Pharmaceutical Preparations | 878 out of 1,549 | 43rd |
Source: SEC filing on April 25, 2022.
Sebree's colleagues
We found two more compensation records of executives who worked with Terri B. Sebree at Zynerba Pharmaceuticals in 2021.
News
Zynerba Pharmaceuticals CEO Armando Anido's 2022 pay slips 15% to $1.9M
April 21, 2023
Zynerba Pharmaceuticals CEO Armando Anido's 2021 pay jumps 49% to $2.2M
April 25, 2022
Zynerba Pharmaceuticals CEO Armando Anido's 2020 pay rises 8% to $1.5M
April 21, 2021
Zynerba Pharmaceuticals CEO Armando Anido's 2019 pay falls 32% to $1.4M
April 23, 2020
Zynerba Pharmaceuticals CEO Armando Anido's 2018 pay slips 18% to $2M
April 25, 2019